Belgium vs Singapore: Proportion of isolates with decreased susceptibility or resistance
Belgium
2.9
in 2018
Singapore
1.5
in 2018
Belgium rank
12th
Singapore rank
14th
Proportion of isolates with decreased susceptibility or resistance over time
- Belgium
- Singapore
How they compare
Belgium currently reports 2.9 against 1.5 in Singapore, a difference of 1.4.
That makes Belgium's figure about 1.9 times Singapore's.
The two have swapped places 4 times across 10 shared years of data; in 2009 it was Belgium ahead.
Belgium ranks 12th and Singapore ranks 14th of 51 countries.
Belgium has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.36 | 1.25 | 5.11 | Belgium |
| 2010s | 5.34 | 2.43 | 2.91 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Belgium or Singapore?
- Belgium, at 2.9 against 1.5 in Singapore as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Belgium and Singapore?
- 1.4, with Belgium ahead.
- How many years of comparable data are there for Belgium and Singapore?
- 10 years are reported by both, from 2009 to 2018.
- How do Belgium and Singapore rank globally for proportion of isolates with decreased susceptibility or resistance?
- Belgium ranks 12th and Singapore ranks 14th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.